Aligos Therapeutics Earnings
NASDAQ: ALGSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.37+0.06 (+1.13%)
Market open · Delayed 15 min · as of Oct 9, 11:08 AM ET
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-2.43
Aligos Therapeutics earnings summary
Aligos Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-2.43.
Summary generated from market data by MetaCap's automated system. Methodology